GNRH1 and inherited lipid metabolism disorder: This study aimed to assess the association between GnRH use/PCa diagnosis and worsening dyslipidaemia through investigating the changes of atherogenic lipid levels, cholesterol ratio and the escalation of lipid-lowering therapy (LLT) in men with T2DM and PCa on/not on GnRH in the nationwide population-based cohorts.